Financial News
Latest News about KNSA
Recent news which mentions KNSA
The Top 7 Growth Stocks in Biotech
March 03, 2023
Tags
DVAX
NASDAQ:ITOS,NASDAQ:VIR,NASDAQ:BEAM,NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:DVAX,NASDAQ:CMRX,NASDAQ:APVO
Market News
From InvestorPlace
5 Value Stocks In The Healthcare Sector
January 09, 2023
From Benzinga
From Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
November 02, 2022
From Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
November 01, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 24, 2022
From Benzinga
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
August 03, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
From Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 11, 2022
From Benzinga
10 Biggest Price Target Changes For Wednesday
December 29, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 28, 2021
From Benzinga
71 Biggest Movers From Yesterday
November 03, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Rises Around 150 Points; Semler Scientific Shares Slide
November 02, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 02, 2021
From Benzinga
64 Biggest Movers From Yesterday
November 02, 2021
From Benzinga
Earnings Scheduled For November 1, 2021
November 01, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
